Keyphrases
Peroxisome Proliferator-activated Receptor
100%
Atorvastatin
100%
PGJ2
100%
Pioglitazone
64%
Small Interfering RNA (siRNA)
21%
Cyclooxygenase-2
14%
Receptor Activation
14%
Human Umbilical Vein Endothelial Cells (HUVECs)
14%
Prostaglandin D2 (PGD2)
14%
Cyclooxygenase-1 (COX-1)
7%
Prostaglandins
7%
Statins
7%
Endogenous Ligand
7%
Reductase Inhibitors
7%
Co-treatment
7%
Rat Heart
7%
Cytosolic Phospholipase A2 (cPLA2)
7%
3-hydroxy-3-methylglutaryl-coenzyme A
7%
Rat Myocardium
7%
Medicine and Dentistry
Peroxisome Proliferator Activated Receptor
100%
Atorvastatin
100%
Pioglitazone
64%
Small Interfering RNA
21%
Endothelial Cell
14%
Synthetase
7%
Myocardium
7%
Prostaglandin
7%
Oxidoreductase
7%
Statin
7%
HMG-CoA
7%
Cyclooxygenase 1 Inhibitor
7%
Cytosolic Phospholipase A2
7%
Pharmacology, Toxicology and Pharmaceutical Science
Atorvastatin
100%
Peroxisome Proliferator Activated Receptor
100%
Pioglitazone
64%
Small Interfering RNA
21%
Synthetase
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Prostaglandin
7%
Oxidoreductase
7%
Cytosolic Phospholipase A2
7%
HMG-CoA
7%
Cyclooxygenase 1 Inhibitor
7%
Biochemistry, Genetics and Molecular Biology
Atorvastatin
100%
Peroxisome Proliferator-Activated Receptor
100%
Pioglitazone
64%
Small Interfering RNA
21%
Synthase
7%
Phospholipase A2
7%
Statin
7%
Oxidoreductase
7%
Reductase
7%
HMG-CoA
7%
Prostaglandin
7%